» Articles » PMID: 37047140

The Interplay Between Integrins and Immune Cells As a Regulator in Cancer Immunology

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Apr 13
PMID 37047140
Authors
Affiliations
Soon will be listed here.
Abstract

Integrins are a group of heterodimers consisting of α and β subunits that mediate a variety of physiological activities of immune cells, including cell migration, adhesion, proliferation, survival, and immunotolerance. Multiple types of integrins act differently on the same immune cells, while the same integrin may exert various effects on different immune cells. In the development of cancer, integrins are involved in the regulation of cancer cell proliferation, invasion, migration, and angiogenesis; conversely, integrins promote immune cell aggregation to mediate the elimination of tumors. The important roles of integrins in cancer progression have provided valuable clues for the diagnosis and targeted treatment of cancer. Furthermore, many integrin inhibitors have been investigated in clinical trials to explore effective regimens and reduce side effects. Due to the complexity of the mechanism of integrin-mediated cancer progression, challenges remain in the research and development of cancer immunotherapies (CITs). This review enumerates the effects of integrins on four types of immune cells and the potential mechanisms involved in the progression of cancer, which will provide ideas for more optimal CIT in the future.

Citing Articles

A Review of Talin- and Integrin-Dependent Molecular Mechanisms in Cancer Invasion and Metastasis.

Baster Z, Russell L, Rajfur Z Int J Mol Sci. 2025; 26(5).

PMID: 40076426 PMC: 11899650. DOI: 10.3390/ijms26051798.


Integrins in Cardiovascular Health and Disease: Molecular Mechanisms and Therapeutic Opportunities.

Lawkowska K, Bonowicz K, Jerka D, Bai Y, Gagat M Biomolecules. 2025; 15(2).

PMID: 40001536 PMC: 11853560. DOI: 10.3390/biom15020233.


Biomechanics in the tumor microenvironment: from biological functions to potential clinical applications.

Peng H, Chao Z, Wang Z, Hao X, Xi Z, Ma S Exp Hematol Oncol. 2025; 14(1):4.

PMID: 39799341 PMC: 11724500. DOI: 10.1186/s40164-024-00591-7.


Subverting to Prevent : Alteration of Effector Immune Cell Migration and Adhesion as a Key Mechanism of Tumor Immune Evasion.

Mastrogiovanni M, Donnadieu E, Pathak R, Di Bartolo V Biology (Basel). 2024; 13(11).

PMID: 39596815 PMC: 11591779. DOI: 10.3390/biology13110860.


Improving tumor microenvironment assessment in chip systems through next-generation technology integration.

Gaebler D, Hachey S, Hughes C Front Bioeng Biotechnol. 2024; 12:1462293.

PMID: 39386043 PMC: 11461320. DOI: 10.3389/fbioe.2024.1462293.


References
1.
Lukacsi S, Gerecsei T, Balazs K, Francz B, Szabo B, Erdei A . The differential role of CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in the adherence, migration and podosome formation of human macrophages and dendritic cells under inflammatory conditions. PLoS One. 2020; 15(5):e0232432. PMC: 7197861. DOI: 10.1371/journal.pone.0232432. View

2.
Lin Y, Cheng Y, Huang J, Lin H, Yang B . Zap70 controls the interaction of talin with integrin to regulate the chemotactic directionality of T-cell migration. Mol Immunol. 2010; 47(11-12):2022-9. DOI: 10.1016/j.molimm.2010.04.011. View

3.
Torres-Gomez A, Cabanas C, Lafuente E . Phagocytic Integrins: Activation and Signaling. Front Immunol. 2020; 11:738. PMC: 7203660. DOI: 10.3389/fimmu.2020.00738. View

4.
Mansour A, Raucci F, Sevim M, Saviano A, Begum J, Zhi Z . Galectin-9 supports primary T cell transendothelial migration in a glycan and integrin dependent manner. Biomed Pharmacother. 2022; 151:113171. DOI: 10.1016/j.biopha.2022.113171. View

5.
Jawhara S, Pluskota E, Cao W, Plow E, Soloviev D . Distinct Effects of Integrins αXβ2 and αMβ2 on Leukocyte Subpopulations during Inflammation and Antimicrobial Responses. Infect Immun. 2016; 85(1). PMC: 5203657. DOI: 10.1128/IAI.00644-16. View